- QMRO Home
- William Harvey Research Institute
- Centre for Experimental Medicine and Rheumatology (EMR)
- Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus
Browse
Administrators only